Video

How Has Immunotherapy Evolved in the Advanced NSCLC Setting?

Author(s):

Joshua Sabari, MD,Nicholas C. Rohs, MD

Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, highlight new therapeutic advances in the advanced setting of non–small cell lung cancer unveiled throughout 2021.

Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, highlight new therapeutic advances in the advanced setting of non–small cell lung cancer unveiled throughout 2021.

Funding from Daiichi Sankyo/Content Independently Developed by OncLive

Related Videos
Josh Sabari, MD
Josh Sabari, MD, of NYU Grossman School of Medicine
Reviewing the Year 2021 in Lung Cancer Treatment
Isabel Preeshagul, DO, MBS
Ashish Saxena, MD, PhD, and Catherine Ann Shu, MD
Isabel Preeshagul, DO, MBS; Catherine Ann Shu, MD; and Ashish Saxena, MD, PhD
Jamie Chaft, MD, and Vamsidhar Velcheti, MD
Joshua K. Sabari, MD
Related Content